跳至主要内容
临床试验/IRCT20161207031288N12
IRCT20161207031288N12招募中2 期

Safety and effectiveness assessment of Dermavisc deep, injectable gel for nasolabial folds correction

Pouragen Company0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • 18 -65 years old men and women
  • Moderate to severe nasolabial folds based on Allergan criteria
  • The opportunity to accompany the visit programs and study process.
  • Signing the infirmed consent form and agree to a 9-month follow-up

排除标准

  • Previous hyaluronic acid (HA)-based dermal filler treatment(s) injected within the last 12 months prior to enrollment
  • Cosmetic facial procedures (chemical peel, laser, radio frequency, dermabrasion, ablative or non-ablative procedures), Botox) in the lower 2/3 of the face, within 3 month prior to study entry
  • Planning to undergo any of these procedures at any time during the study

研究者

发起方
Pouragen Company

相似试验

Safety and effectiveness assessment of Dermavisc deep | 临床试验